EUVIMEDEUVIMED entdecken
Crossref

Cytosol‐Targeting Delivery of Non‐Nucleotide STING Agonist Achieves Inhalable Nanoparticle‐Based Anthrax Vaccine

Xi Zhang, Chenxi Dai, Hanchen Zhang, Yaling Wang, Xiaolin Song, Shengnan Fu, Zhixin Li, Haihua Xiao, Zeliang Chen, Dongsheng Zhou iD

Advanced Materials · 2026-05 · 38 (28)

DOI: 10.1002/adma.202512910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 20.04.2026. Verfasst von Xi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Veterinary Medicine, Shenyang Agricultural University, Shenyang, China. Hauptthemen laut MEDLINE: Anthrax Vaccines, Nanoparticles, Cytosol, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Key R&D Program of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhalational anthrax is a deadly disease caused by inhalation of Bacillus anthracis spores. Current anthrax vaccines for human use have limitations including undefined components, limited mucosal immunity, and suboptimal adjuvant delivery. This study introduces 2 polymers, MP1 and MP2, each containing disulfide bonds. MP1 incorporates tertiary amines to induce proton sponge effect, while MP2 features terminal phenylboronic acid moieties for protein conjugation. Nanoparticle vaccine YM1.7 is created through self‐assembly of MP1, MP2, and STING agonist MSA‐2, followed by N─B coordination of recombinant protein antigen (rPA) on its surface. When administered via aerosolized intratracheal inoculation into the lung, YM1.7 is internalized by antigen‐presenting cell and trafficked to the lysosome, where acidic environment dissociates N─B bond, releasing rPA for antigen presentation. Proton sponge effect allows nanoparticle to escape into the cytosol, and then disulfide bond cleavage triggered by cytosolic glutathione causes dissociation of nanoparticle and release of MSA‐2 within the cytosol, significantly enhancing bioavailability of MSA‐2 as an adjuvant. This spatiotemporal delivery mechanism elicits a coordinated innate, humoral, mucosal, and cell‐mediated immune response in mice, providing strong protection against inhalational anthrax. Given its modular design nature, YM1.7 represents a promising platform for developing next‐generation mucosal vaccines against infections and cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anthrax VaccinesNanoparticlesCytosolMembrane ProteinsAnimalsMiceSTING ProteinNanovaccinesAdministration, InhalationAnthraxcGAS-STING Signaling PathwayAntigens, BacterialHumansBacillus anthracis

Stichwörter der Autor:innen

MSA‐2aerosolized intratracheal inoculationcytosol‐targeting deliveryinhalational anthraxnanoparticle vaccine

Substanzen

Anthrax VaccinesMembrane ProteinsSTING ProteinNanovaccinesAntigens, Bacterial

Autor:innen und Institutionen

  • College of Animal Science and Veterinary Medicine, Shenyang Agricultural University, Shenyang, China.
  • State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.
  • Beijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.
  • CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, Beijing, China.

ORCID-Profile: Dongsheng Zhou

Förderung

  • National Key R&D Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, X., Dai, C., Zhang, H., Wang, Y., Song, X., Fu, S., Li, Z., Xiao, H., Chen, Z., & Zhou, D. (2026). Cytosol‐Targeting Delivery of Non‐Nucleotide STING Agonist Achieves Inhalable Nanoparticle‐Based Anthrax Vaccine. Advanced Materials, 38(28). https://doi.org/10.1002/adma.202512910

Vancouver

Zhang X, Dai C, Zhang H, Wang Y, Song X, Fu S, et al. Cytosol‐Targeting Delivery of Non‐Nucleotide STING Agonist Achieves Inhalable Nanoparticle‐Based Anthrax Vaccine. Advanced Materials. 2026;38(28). doi:10.1002/adma.202512910

BibTeX
@article{Zhang2026,
  author = {Zhang, Xi and Dai, Chenxi and Zhang, Hanchen and Wang, Yaling and Song, Xiaolin and Fu, Shengnan and Li, Zhixin and Xiao, Haihua and Chen, Zeliang and Zhou, Dongsheng},
  title = {Cytosol‐Targeting Delivery of Non‐Nucleotide STING Agonist Achieves Inhalable Nanoparticle‐Based Anthrax Vaccine},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {28},
  doi = {10.1002/adma.202512910}
}
Kostenlos starten →